New type 1 diabetes therapy shows promise for long-term reversal in both humans, dogs

A collagen formulation mixed with pancreatic cells is the first minimally invasive therapy to successfully reverse Type 1 diabetes within 24 hours and maintain insulin independence for at least 90 days, a pre-clinical animal study shows.